Tilray Brands, Inc. Income (Loss) from Equity Method Investments
Tilray Brands, Inc. (TLRY) reported Income (Loss) from Equity Method Investments of -$215.00 thousand for the 3-month period ending 2023-08-31, per its 10-Q filed 2024-10-10.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2024-10-10
- Tilray Brands, Inc. income (loss) from equity method investments for the quarter ending 2023-08-31 was -$215.00K.
- Tilray Brands, Inc. income (loss) from equity method investments for the quarter ending 2023-05-31 was -$426.00K, a 110.03% decline year-over-year.
- Tilray Brands, Inc. income (loss) from equity method investments for the quarter ending 2023-02-28 was -$1.37M.
- Tilray Brands, Inc. income (loss) from equity method investments for the quarter ending 2022-11-30 was -$6.10M, a 666.39% decline year-over-year.
- Tilray Brands, Inc. income (loss) from equity method investments for fiscal 2023 was -$7.97M, a 253.05% decline from fiscal 2022.
- Tilray Brands, Inc. income (loss) from equity method investments for fiscal 2022 was $5.21M, a 42.64% decline from fiscal 2021.
- Tilray Brands, Inc. income (loss) from equity method investments for fiscal 2021 was $9.08M.
- Tilray Brands, Inc. income (loss) from equity method investments for fiscal 2020 was -$5.98M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2023-08-31 | -$215.00K 10-Q · filed 2024-10-10 | -$641.00K derived: sum of 2 quarters · filed 2024-10-10 | -$2.01M derived: sum of 3 quarters · filed 2024-10-10 | -$8.11M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2023-05-31 | -$426.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$1.80M derived: sum of 2 quarters · filed 2023-07-26 | -$7.90M derived: sum of 3 quarters · filed 2023-07-26 | -$7.97M 10-K · filed 2023-07-26 | |
| 2023-02-28 | -$1.37M 10-Q · filed 2023-04-10 | -$7.47M derived: sum of 2 quarters · filed 2023-04-10 | -$7.54M 10-Q · filed 2023-04-10 | -$3.30M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-11-30 | -$6.10M 10-Q · filed 2023-01-09 | -$6.17M 10-Q · filed 2023-01-09 | -$1.93M derived: sum of 3 quarters · filed 2024-10-10 | -$2.23M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-08-31 | -$75.00K 10-Q · filed 2024-10-10 | $4.17M derived: sum of 2 quarters · filed 2024-10-10 | $3.87M derived: sum of 3 quarters · filed 2024-10-10 | $4.94M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-05-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $3.94M derived: sum of 2 quarters · filed 2023-07-26 | $5.02M derived: sum of 3 quarters · filed 2023-07-26 | $5.21M 10-K · filed 2023-07-26 | |
| 2022-02-28 | -$306.00K 10-Q · filed 2023-04-10 | $771.00K derived: sum of 2 quarters · filed 2023-04-10 | $962.00K 10-Q · filed 2023-04-10 | ||
| 2021-11-30 | $1.08M 10-Q · filed 2023-01-09 | $1.27M 10-Q · filed 2023-01-09 | |||
| 2021-05-31 | $9.08M 10-K · filed 2023-07-26 | -$458.00K 10-K · filed 2021-07-28 | |||
| 2021-03-31 | -$1.79M 10-Q · filed 2021-05-10 | -$3.27M derived: sum of 2 quarters · filed 2021-05-10 | -$4.70M derived: sum of 3 quarters · filed 2021-05-10 | -$6.02M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$2.91M derived: sum of 2 quarters · filed 2021-02-19 | -$4.24M derived: sum of 3 quarters · filed 2021-02-19 | -$5.98M 10-K · filed 2021-02-19 | |
| 2020-09-30 | -$1.42M 10-Q · filed 2020-11-09 | -$2.75M derived: sum of 2 quarters · filed 2020-11-09 | -$4.50M 10-Q · filed 2020-11-09 | -$7.16M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-06-30 | -$1.33M 10-Q · filed 2020-08-10 | -$3.08M 10-Q · filed 2020-08-10 | -$5.74M derived: sum of 3 quarters · filed 2021-05-10 | -$7.58M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-03-31 | -$1.75M 10-Q · filed 2021-05-10 | -$4.42M derived: sum of 2 quarters · filed 2021-05-10 | -$6.25M derived: sum of 3 quarters · filed 2021-05-10 | ||
| 2019-12-31 | -$2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$4.50M derived: sum of 2 quarters · filed 2021-02-19 | -$4.50M 10-K · filed 2021-02-19 | ||
| 2019-09-30 | -$1.84M 10-Q · filed 2020-11-09 | -$1.84M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |